Epistatic Interactions between Apolipoprotein E and Hemoglobin S Genes in Regulation of Malaria Parasitemia

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Rougeron, Virginie ^a   Woods, Caira M ^a   Tiedje, Kathryn E ^a   Bodeau Livinec, Florence ^a,b   Migot Nabias, Florence ^b   Deloron, Philippe ^b,c   Luty, Adrian J F ^b   Fowkes, Freya J I ^a,d   Day, Karen P ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d BURNET INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 2; APOLIPOPROTEIN E EPSILON 3; APOLIPOPROTEIN E EPSILON 4; CHOLESTEROL; HEMOGLOBIN S; ISOPROTEIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CELL INVASION; CHILD; CROSS-SECTIONAL STUDY; EPISTASIS; FEMALE; GABON; GENE EXPRESSION; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC REGULATION; HUMAN; LIVER CELL; MAJOR CLINICAL STUDY; MALE; MICROBIAL GROWTH; NONHUMAN; PARASITE IDENTIFICATION; PARASITEMIA; PHENOTYPE; PLASMODIUM; POPULATION DENSITY; SCREENING TEST; SEASON; SICKLE CELL TRAIT;

ALLELES; APOLIPOPROTEINS E; CHILD; CHILD, PRESCHOOL; EPISTASIS, GENETIC; FEMALE; GABON; GENOTYPE; HEMOGLOBIN A; HEMOGLOBIN, SICKLE; HOST-PARASITE INTERACTIONS; HUMANS; INFANT; MALARIA; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; SPECIES SPECIFICITY;

EID: 84885100031     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076924     Document Type: Article

References (60)

1. Bruce MC, Galinski MR, Barnwell JW, Donnelly CA, Walmsley M, et al. (2000) Genetic diversity and dynamics of Plasmodium falciparum and P. vivax populations in multiply infected children with asymptomatic malaria infections in Papua New Guinea. Parasitology 121(Pt 3):: 257-272. doi:10.1017/S0031182099006356. PubMed: 11085246.
2. Rogier C, (2000) Natural history of Plasmodium falciparum malaria and determining factors of the acquisition of antimalaria immunity in two endemic areas, Dielmo and Ndiop (Senegal). Bull Mem Acad R Med Belg 155: 218-226. PubMed: 11304957.
3. Rogier C, Commenges D, Trape JF, (1996) Evidence for an age-dependent pyrogenic threshold of Plasmodium falciparum parasitemia in highly endemic populations. Am J Trop Med Hyg 54: 613-619. PubMed: 8686780.
4. Kwiatkowski DP, (2005) How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 77: 171-192. doi:10.1086/432519. PubMed: 16001361.
5. Taylor SM, Parobek CM, Fairhurst RM, (2012) Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis. Lancet Infect Dis 12: 457-468. doi:10.1016/S1473-3099(12)70055-5. PubMed: 22445352.
6. Fowkes FJ, Imrie H, Migot-Nabias F, Michon P, Justice A, et al. (2006) Association of haptoglobin levels with age, parasite density, and haptoglobin genotype in a malaria-endemic area of Gabon. Am J Trop Med Hyg 74: 26-30. PubMed: 16407342.
7. Fowkes FJ, Michon P, Pilling L, Ripley RM, Tavul L, et al. (2008) Host erythrocyte polymorphisms and exposure to Plasmodium falciparum in Papua New Guinea. Malar J 7: 1. doi:10.1186/1475-2875-7-1. PubMed: 18173836.
8. Imrie H, Fowkes FJ, Michon P, Tavul L, Hume JC, et al. (2006) Haptoglobin levels are associated with haptoglobin genotype and alpha+-Thalassemia in a malaria-endemic area. Am J Trop Med Hyg 74: 965-971. PubMed: 16760505.
9. Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, et al. (1993) A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261: 1182-1184. doi:10.1126/science.7689250. PubMed: 7689250.
10. Kasehagen LJ, Mueller I, Kiniboro B, Bockarie MJ, Reeder JC, et al. (2007) Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes. PLOS ONE 2: e336. doi:10.1371/journal.pone.0000336. PubMed: 17389925.
11. Ménard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, et al. (2010) Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci U S A 107: 5967-5971. doi:10.1073/pnas.0912496107. PubMed: 20231434.
12. Zimmerman PA, Woolley I, Masinde GL, Miller SM, McNamara DT, et al. (1999) Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea. Proc Natl Acad Sci U S A 96: 13973-13977. doi:10.1073/pnas.96.24.13973. PubMed: 10570183.
13. Mackinnon MJ, Mwangi TW, Snow RW, Marsh K, Williams TN, (2005) Heritability of malaria in Africa. PLOS Med 2: e340. doi:10.1371/journal.pmed.0020340. PubMed: 16259530.
14. Solovieff N, Milton JN, Hartley SW, Sherva R, Sebastiani P, et al. (2010) Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster. Blood 115: 1815-1822. doi:10.1182/blood-2009-08-239517. PubMed: 20018918.
15. Ribalta J, Vallvé JC, Girona J, Masana L, (2003) Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease. Curr Opin Clin Nutr Metab Care 6: 177-187. doi:10.1097/00075197-200303000-00006. PubMed: 12589187.
16. Siest G, Pillot T, Régis-Bailly A, Leininger-Muller B, Steinmetz J, et al. (1995) Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 41: 1068-1086. PubMed: 7628082.
17. Boerwinkle E, Utermann G, (1988) Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet 42: 104-112. PubMed: 3337104.
18. Gregg RE, Brewer HB Jr., (1988) The role of apolipoprotein E and lipoprotein receptors in modulating the in vivo metabolism of apolipoprotein B-containing lipoproteins in humans. Clin Chem 34: B28-B32. PubMed: 2841050.
19. Mamotte CD, Sturm M, Foo JI, van Bockxmeer FM, Taylor RR, (1999) Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes. Am J Physiol 276: E553-E557. PubMed: 10070023.
20. Weisgraber KH, (1994) Apolipoprotein E: structure-function relationships. Adv Protein Chem 45: 249-302. doi:10.1016/S0065-3233(08)60642-7. PubMed: 8154371.
21. Corbo RM, Scacchi R, (1999) Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele? Ann Hum Genet 63: 301-310. doi:10.1046/j.1469-1809.1999.6340301.x. PubMed: 10738542.
22. Hanlon CS, Rubinsztein DC, (1995) Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans. Atherosclerosis 112: 85-90. doi:10.1016/0021-9150(94)05402-5. PubMed: 7772071.
23. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923. doi:10.1126/science.8346443. PubMed: 8346443.
24. Gerdes LU, Gerdes C, Kervinen K, Savolainen M, Klausen IC, et al. (2000) The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction: a substudy of the Scandinavian simvastatin survival study. Circulation 101: 1366-1371. doi:10.1161/01.CIR.101.12.1366. PubMed: 10736278.
25. Katzman R, (1994) Apolipoprotein E and Alzheimer's disease. Curr Opin Neurobiol 4: 703-707. doi:10.1016/0959-4388(94)90013-2. PubMed: 7849527.
26. Mahley RW, Rall SC Jr., (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1: 507-537. doi:10.1146/annurev.genom.1.1.507. PubMed: 11701639.
27. Corder EH, Blennow K, Prince JA, (2008) Genetic susceptibility sets for Alzheimer's disease identified from diverse candidate loci. Rejuvenation Res 11: 667-679. doi:10.1089/rej.2008.0742. PubMed: 18593285.
28. Corder EH, Paganelli R, Giunta S, Franceschi C, (2008) Differential course of HIV-1 infection and APOE polymorphism. Proc Natl Acad Sci U S A 105: E87. doi:10.1073/pnas.0808164105. PubMed: 19004794.
29. Kuhlmann I, Minihane AM, Huebbe P, Nebel A, Rimbach G, (2010) Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review. Lipids Health Dis 9: 8. doi:10.1186/1476-511X-9-8. PubMed: 20109174.
30. Gregg RE, Brewer HB Jr., (1986) In vivo metabolism of apolipoprotein E in humans. Methods Enzymol 129: 482-497. doi:10.1016/0076-6879(86)29087-4. PubMed: 3523156.
31. Lucotte G, Loirat F, Hazout S, (1997) Pattern of gradient of apolipoprotein E allele *4 frequencies in western Europe. Hum Biol 69: 253-262. PubMed: 9057348.
32. Utermann G, Kindermann I, Kaffarnik H, Steinmetz A, (1984) Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet 65: 232-236. doi:10.1007/BF00286508. PubMed: 6698547.
33. Weintraub MS, Eisenberg S, Breslow JL, (1987) Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 80: 1571-1577. doi:10.1172/JCI113243. PubMed: 3479440.
34. Bansal D, Bhatti HS, Sehgal R, (2005) Role of cholesterol in parasitic infections. Lipids Health Dis 4: 10. doi:10.1186/1476-511X-4-10. PubMed: 15882457.
35. Jayabalasingham B, Bano N, Coppens I, (2010) Metamorphosis of the malaria parasite in the liver is associated with organelle clearance. Cell Res 20: 1043-1059. doi:10.1038/cr.2010.88. PubMed: 20567259.
36. Jayabalasingham B, Menard R, Fidock DA, (2010) Recent insights into fatty acid acquisition and metabolism in malarial parasites. F1000. Biol Reprod 2.
37. Labaied M, Jayabalasingham B, Bano N, Cha SJ, Sandoval J, et al. (2011) Plasmodium salvages cholesterol internalized by LDL and synthesized de novo in the liver. Cell Microbiol 13: 569-586. doi:10.1111/j.1462-5822.2010.01555.x. PubMed: 21105984.
38. Rathore D, Kumar S, Lanar DE, McCutchan TF, (2001) Disruption of disulfide linkages of the Plasmodium falciparum circumsporozoite protein: effects on cytotoxic and antibody responses in mice. Mol Biochem Parasitol 118: 75-82. doi:10.1016/S0166-6851(01)00369-3. PubMed: 11704275.
39. Rathore D, Sacci JB, de la Vega P, McCutchan TF, (2002) Binding and invasion of liver cells by Plasmodium falciparum sporozoites. Essential involvement of the amino terminus of circumsporozoite protein. J Biol Chem 277: 7092-7098. doi:10.1074/jbc.M106862200. PubMed: 11751898.
40. Shakibaei M, Frevert U, (1996) Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans. J Exp Med 184: 1699-1711. doi:10.1084/jem.184.5.1699. PubMed: 8920859.
41. Sinnis P, Willnow TE, Briones MR, Herz J, Nussenzweig V, (1996) Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes. J Exp Med 184: 945-954. doi:10.1084/jem.184.3.945. PubMed: 9064354.
42. Vignali M, McKinlay A, LaCount DJ, Chettier R, Bell R, et al. (2008) Interaction of an atypical Plasmodium falciparum ETRAMP with human apolipoproteins. Malar J 7: 211. doi:10.1186/1475-2875-7-211. PubMed: 18937849.
43. Fairhurst RM, Wellems TE, (2006) Modulation of malaria virulence by determinants of Plasmodium falciparum erythrocyte membrane protein-1 display. Curr Opin Hematol 13: 124-130. doi:10.1097/01.moh.0000219655.73162.42. PubMed: 16567953.
44. Frankland S, Adisa A, Horrocks P, Taraschi TF, Schneider T, et al. (2006) Delivery of the malaria virulence protein PfEMP1 to the erythrocyte surface requires cholesterol-rich domains. Eukaryot Cell 5: 849-860. doi:10.1128/EC.5.5.849-860.2006. PubMed: 16682462.
45. Parquet V, Briolant S, Torrentino-Madamet M, Henry M, Almeras L, et al. (2009) Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria. Antimicrob Agents Chemother 53: 2248-2252. doi:10.1128/AAC.01462-08. PubMed: 19307369.
46. Parquet V, Henry M, Wurtz N, Dormoi J, Briolant S, et al. (2010) Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum. Malar J 9: 139. doi:10.1186/1475-2875-9-139. PubMed: 20497586.
47. Taoufiq Z, Pino P, N'Dilimabaka N, Arrouss I, Assi S, et al. (2011) Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage. Malar J 10: 52. doi:10.1186/1475-2875-10-52. PubMed: 21356073.
48. Aucan C, Walley AJ, Hill AV, (2004) Common apolipoprotein E polymorphisms and risk of clinical malaria in the Gambia. J Med Genet 41: 21-24. doi:10.1136/jmg.2003.012104. PubMed: 14729824.
49. Wozniak MA, Faragher EB, Todd JA, Koram KA, Riley EM, et al. (2003) Does apolipoprotein E polymorphism influence susceptibility to malaria? J Med Genet 40: 348-351. doi:10.1136/jmg.40.5.348. PubMed: 12746397.
50. Elissa N, Migot-Nabias F, Luty A, Renaut A, Touré F, et al. (2003) Relationship between entomological inoculation rate, Plasmodium falciparum prevalence rate, and incidence of malaria attack in rural Gabon. Acta Trop 85: 355-361. doi:10.1016/S0001-706X(02)00266-8. PubMed: 12659973.
51. Ntoumi F, Ekala MT, Makuwa M, Lekoulou F, Mercereau-Puijalon O, et al. (2002) Sickle cell trait carriage: imbalanced distribution of IgG subclass antibodies reactive to Plasmodium falciparum family-specific MSP2 peptides in serum samples from Gabonese children. Immunol Lett 84: 9-16. doi:10.1016/S0165-2478(02)00131-1. PubMed: 12161278.
52. Migot-Nabias F, Mombo LE, Luty AJ, Dubois B, Nabias R, et al. (2000) Human genetic factors related to susceptibility to mild malaria in Gabon. Genes Immun 1: 435-441. doi:10.1038/sj.gene.6363703. PubMed: 11196674.
53. Cox MJ, Kum DE, Tavul L, Narara A, Raiko A, et al. (1994) Dynamics of malaria parasitaemia associated with febrile illness in children from a rural area of Madang, Papua New Guinea. Trans R Soc Trop Med Hyg 88: 191-197. doi:10.1016/0035-9203(94)90292-5. PubMed: 8036670.
54. Crook R, Hardy J, Duff K, (1994) Single-day apolipoprotein E genotyping. J Neurosci Methods 53: 125-127. doi:10.1016/0165-0270(94)90168-6. PubMed: 7823614.
55. Wenham PR, Price WH, Blandell G, (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337: 1158-1159. doi:10.1016/0140-6736(91)92823-K. PubMed: 1674030.
56. Falk N, Maire N, Sama W, Owusu-Agyei S, Smith T, et al. (2006) Comparison of PCR-RFLP and Genescan-based genotyping for analyzing infection dynamics of Plasmodium falciparum. Am J Trop Med Hyg 74: 944-950. PubMed: 16760501.
57. Coombs JA, Letcher BH, Nislow KH, (2008) create: a software to create input files from diploid genotypic data for 52 genetic software programs. Mol Ecol Resour 8: 578-580. doi:10.1111/j.1471-8286.2007.02036.x. PubMed: 21585837.
58. Goudet J, (2002) STAT, aprogram to estimate and test gene diversities and fixation indices (version 2.9.3).
59. Goudet J, (1995) FSTAT (Version 1.2): A computer program to calculate F-statistics. J Hered 86: 485-486.
60. Eisenberg DT, Kuzawa CW, Hayes MG, (2010) Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history. Am J Phys Anthropol 143: 100-111. PubMed: 20734437.